Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22)

References

• Kasturiratne A, Wickremasinghe AR, de Silva N, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5:e218.
   PubMed Web of Science ®Google Scholar
• de Silva HA, Pathmeswaran A, Ranasinha CD, et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8:e1000435.
   PubMed Web of Science ®Google Scholar
• Fan HW, Marcopito LF, Cardoso JL, et al. Sequential randomised and double blind trial of promethazine prophylaxis against early anaphylactic reactions to antivenom for bothrops snake bites. BMJ. 1999;318:1451–1452.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Brown SG. Bites in Australian snake handlers – Australian snakebite project (ASP-15). QJM. 2012;105:1089–1095.
   PubMed Web of Science ®Google Scholar
• Premawardhena AP, de Silva CE, Fonseka MM, et al. Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial. BMJ. 1999;318:1041–1043.
   PubMed Web of Science ®Google Scholar
• Clark RF, McKinney PE, Chase PB, Walter FG. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom. Ann Emerg Med. 2002;39:671–676.
   PubMed Web of Science ®Google Scholar
• Dart RC, McNally J. Efficacy, safety, and use of snake antivenoms in the United States. Ann Emerg Med. 2001;37:181–188.
   PubMed Web of Science ®Google Scholar
• Amin MR, Mamun SMH, Rashid R, et al. Anti-snake venom: use and adverse reaction in a snake bite study clinic in Bangladesh. J Venom Anim Toxins incl Trop Dis. 2008;14:660–672.
   Web of Science ®Google Scholar
• Thiansookon A, Rojnuckarin P. Low incidence of early reactions to horse-derived F(ab′)2 antivenom for snakebites in Thailand. Acta Tropica. 2008;105:203–205.
   PubMed Web of Science ®Google Scholar
• Leon G, Herrera M, Segura A, et al. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. Toxicon. 2013;76:63–76.
   PubMed Web of Science ®Google Scholar
• Kraus R. Uber spezifische Reaktionen in keimfreien Filtraten aus Cholera, Typhus and Pestbouillonkulturen, erzeugt durch homologues Serum. Wien Klin Wochschr. 1897;10:736–738.
   Google Scholar
• von Pirquet CF. Allergie. Arch Intern Med. 1911;7:258–288, 383–440.
   Google Scholar
• Lawley TJ, Bielory L, Gascon P, et al. A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med. 1984;311:1407–1413.
   PubMed Web of Science ®Google Scholar
• Silverstein AM. Clemens Freiherr von Pirquet: explaining immune complex disease in 1906. Nat Immunol. 2000;1:453–455.
   PubMed Web of Science ®Google Scholar
• LoVecchio F, Klemens J, Roundy EB, Klemens A. Serum sickness following administration of antivenin (Crotalidae) polyvalent in 181 cases of presumed rattlesnake envenomation. Wilderness Environ Med. 2003;14:220–221.
   PubMed Web of Science ®Google Scholar
• Abubakar IS, Abubakar SB, Habib AG, et al. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria. PLoS Negl Trop Dis. 2010;4:e767.
   Google Scholar
• Otero-Patino R, Segura A, Herrera M, et al. Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab′)2] antivenoms, in Bothrops asper bites in Colombia. Toxicon. 2012;59:344–355.
   PubMed Web of Science ®Google Scholar
• Allen GE, Brown SG, Buckley NA, et al. Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming – Australian snakebite project (ASP-14). PLoS One. 2012;7:e53188.
   PubMed Web of Science ®Google Scholar
• Gan M, O’Leary MA, Brown SG, et al. Envenoming by the rough-scaled snake (Tropidechis carinatus): a series of confirmed cases. Med J Aust. 2009;191:183–186.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Brown SG, MacDonald E, et al. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust. 2008;188:473–476.
   PubMed Web of Science ®Google Scholar
• Isbister GK, O’Leary MA, Elliott M, Brown SG. Tiger snake (Notechis spp) envenoming: Australian Snakebite Project (ASP-13). Med J Aust. 2012;197:173–177.
   PubMed Web of Science ®Google Scholar
• Lavonas EJ, Kokko J, Schaeffer TH, , et al. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2011;57:128–137.e3.
   PubMed Web of Science ®Google Scholar
• Bush SP, Green SM, Moynihan JA, et al. Crotalidae polyvalent immune fab (ovine) antivenom is efficacious for envenomations by southern pacific rattlesnakes (Crotalus helleri). Ann Emerg Med. 2002;40:619–624.
   PubMed Web of Science ®Google Scholar
• Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161:2030–2036.
   PubMed Web of Science ®Google Scholar
• Lavonas EJ, Gerardo CJ, O’Malley G, et al. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. 2004;43:200–206.
   PubMed Web of Science ®Google Scholar
• Ruha AM, Curry SC, Beuhler M, et al. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med. 2002;39:609–615.
   PubMed Web of Science ®Google Scholar
• Campbell CH. Antivenene in the treatment of Australian and Papuan snake bite. Med J Aust. 1967;2:106–110.
   PubMedGoogle Scholar
• Trinca GF. The treatment of snakebite. Med J Aust. 1963;50:275–280.
   PubMedGoogle Scholar
• Nielsen H, Sorensen H, Faber V, Svehag SE. Circulating immune complexes, complement activation kinetics and serum sickness following treatment with heterologous anti-snake venom globulin. Scand J Immunol. 1978;7:25–33.
   PubMed Web of Science ®Google Scholar
• Nordt SP, Clark RF. Rattlesnakes and other crotalids. In: Ford MD, Delaney KA, Ling LJ, Erickson T, editors. Clinical Toxicology. Philadelphia, PA: WB Saunders Co; 2000. p. 863–872.
   Google Scholar
• Morais V, Negrin A, Tortorella MN, Massaldi H. Evolution of venom antigenaemia and antivenom concentration in patients bitten by snakes in Uruguay. Toxicon. 2012;60:990–994.
   PubMed Web of Science ®Google Scholar
• Jurkovich GJ, Luterman A, McCullar K, et al. Complications of Crotalidae antivenin therapy. J Trauma. 1988;28:1032–1037.
   PubMed Web of Science ®Google Scholar
• Steinberg E, Russell F, Underman A. Preliminary clinical observations with prophylactic cyproheptadine hydrochloride in potential serum reactions to antivenins. In: Rosenberg P, editor. Toxin: animal, plant and microbial. Oxford: Pergamon Press; 1978. p. 489–493.
   Google Scholar
• Nuchpraryoon I, Garner P. Interventions for preventing reactions to snake antivenom. Cochrane Database Syst Rev. 2000:CD002153.
   Google Scholar
• Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002;347:347–356.
   PubMed Web of Science ®Google Scholar